Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Cash & Current Investments came in at $39.7 million in Q1 2026, up 52.92% year-on-year from $26.0 million in Q1 2025, and up 65.1% on a QoQ basis from $24.0 million in Q4 2025.
Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash & Current Investments data on file, last reported at $39.7 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments rose 52.92% year-over-year to $39.7 million in Q1 2026; TTM through Mar 2026 was $39.7 million, a 52.92% increase from a year earlier, with the FY2025 full-year figure at $24.0 million, up 23.19% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $39.7 million, up from $24.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for JUSHF reached as high as $43.2 million in Q2 2022 and fell as low as $18.5 million in Q1 2023.
- Historically, Cash & Current Investments has averaged $27.7 million across 5 years, with a median of $27.3 million in 2022.
- Across the five-year window, Cash & Current Investments sank 72.41% in 2022 and soared 53.81% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $26.2 million in 2022, then increased by 11.3% to $29.2 million in 2023, then slumped by 33.04% to $19.5 million in 2024, then gained by 23.19% to $24.0 million in 2025, then jumped by 65.1% to $39.7 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $39.7 million in Q1 2026, $24.0 million in Q4 2025, and $23.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 39.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.70 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 23.21 Mn |
| Mar 31, 2025 | 25.96 Mn |
| Dec 31, 2024 | 19.52 Mn |
| Sep 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 32.88 Mn |
| Mar 31, 2024 | 28.41 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.32 Mn |
| Jun 30, 2023 | 29.91 Mn |
| Mar 31, 2023 | 18.47 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 43.19 Mn |
| Dec 31, 2021 | 94.96 Mn |